Valuation Tiansheng Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 22/10/2026			5-day change	1st Jan Change
5.560 ^CNY	-1.42%		-1.77%	+14.40%

08-24	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05-08	Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,507	1,660	1,679	1,631	1,444	1,545
Change	-	10.13%	1.15%	-2.84%	-11.5%	7.05%
Enterprise Value (EV) ¹	1,762	1,653	1,730	1,764	1,541	1,624
Change	-	-6.17%	4.65%	1.98%	-12.66%	5.42%
P/E	-3.07x	-24.5x	-18.5x	-17.5x	-16.5x	-27.9x
PBR	0.64x	0.73x	0.77x	0.78x	0.72x	0.79x
PEG	-	0.3x	-0.6x	-6.31x	2.71x	0.8x
Capitalization / Revenue	1.25x	2.25x	2.77x	2.82x	2.53x	3.01x
EV / Revenue	1.46x	2.24x	2.85x	3.05x	2.7x	3.16x
EV / EBITDA	-308x	68.3x	151x	97.8x	34.2x	25.3x
EV / EBIT	-14.4x	-22.8x	-18.5x	-20.5x	-25.4x	-29.4x
EV / FCF	9.44x	9.13x	-46.4x	-30.5x	26.6x	21.1x
FCF Yield	10.6%	11%	-2.16%	-3.28%	3.76%	4.74%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-1.543	-0.2132	-0.2848	-0.2927	-0.2749	-0.1743
Distribution rate	-	-	-	-	-	-
Net sales ¹	1,203	736.7	607	579.3	569.7	514.1
EBITDA ¹	-5.721	24.22	11.48	18.03	45.11	64.11
EBIT ¹	-122.6	-72.44	-93.65	-85.96	-60.56	-55.26
Net income ¹	-490.7	-67.81	-90.56	-93.07	-87.4	-55.42
Net Debt ¹	254.5	-6.895	50.92	132.9	97.19	78.93
Reference price ²	4.740	5.220	5.280	5.130	4.540	4.860
Nbr of stocks (in thousands)	318,000	318,000	318,000	318,000	318,000	318,000
Announcement Date	26/04/21	24/04/22	26/04/23	25/04/24	28/04/25	28/04/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TIANSHENG PHARMACEUTICAL GROUP CO., LTD.	-	-	-	-	269M
ELI LILLY AND COMPANY	36.67x	13.07x	27.74x	0.54%	1,133B
JOHNSON & JOHNSON	37.73x	6.36x	17.89x	2.07%	621B
ABBVIE INC.	36.35x	8.36x	17.26x	2.41%	503B
ROCHE HOLDING AG	21.21x	5.12x	12.74x	2.55%	379B
MERCK & CO., INC.	109.25x	6.09x	26.14x	2.27%	370B
NOVARTIS AG	21.57x	5.62x	13.82x	2.84%	292B
ASTRAZENECA PLC	22.08x	4.46x	12.77x	1.98%	262B
AMGEN INC.	27.83x	7.14x	12.79x	2.3%	237B
GILEAD SCIENCES, INC.	-44.76x	6.88x	26.67x	2.15%	190B
Average	29.77x	7.01x	18.64x	2.12%	398.83B
Weighted average by Cap.	35.57x	8.27x	20.36x	1.81%